Lower demand for SRT systems reflects the impact of inflation on dermatologists’ cash flow from fewer elective aesthetic procedures and higher operating costs
Sensus expects to ship more than 60 SRT units during 2023 and return to profitability in the second half of the year
https://finance.yahoo.com/news/sensus-healthcare-reports-first-quarter-200500907.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.